ARCUTIS BIOTHERAPEUTICS INC

Ticker: ARQT CUSIP: 03969K108 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 454,233 Value ($000) $13,191 Avg Close $25.60 Range $18.79 - $31.77

Q3 2025

Shares 18,300 Value ($000) $345 Avg Close $15.77 Range $13.06 - $19.36

Q1 2025

Shares 57,908 Value ($000) $906 Avg Close $14.09 Range $11.13 - $17.75

Q4 2023

Shares 95,011 Value ($000) $307 Avg Close $2.72 Range $1.76 - $5.26

Q3 2023

Shares 2,311,077 Value ($000) $12,272 Avg Close $8.50 Range $5.19 - $11.39

Q2 2023

Shares 2,317,541 Value ($000) $22,086 Avg Close $11.10 Range $7.25 - $15.40

Q1 2023

Shares 2,305,336 Value ($000) $25,359 Avg Close $14.47 Range $10.05 - $17.57

Q3 2022

Shares 167,816 Value ($000) $3,208 Avg Close $22.66 Range $17.01 - $27.40

Q2 2021

Shares 15,138 Value ($000) $413 Avg Close $28.17 Range $23.77 - $36.45

Q1 2021

Shares 169,487 Value ($000) $4,903 Avg Close $31.23 Range $24.25 - $38.49

Q4 2020

Shares 78,973 Value ($000) $2,222 Avg Close $24.49 Range $17.51 - $32.21

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	454,233	$13,191	$25.60	$18.79 - $31.77
Q3 2025	18,300	$345	$15.77	$13.06 - $19.36
Q1 2025	57,908	$906	$14.09	$11.13 - $17.75
Q4 2023	95,011	$307	$2.72	$1.76 - $5.26
Q3 2023	2,311,077	$12,272	$8.50	$5.19 - $11.39
Q2 2023	2,317,541	$22,086	$11.10	$7.25 - $15.40
Q1 2023	2,305,336	$25,359	$14.47	$10.05 - $17.57
Q3 2022	167,816	$3,208	$22.66	$17.01 - $27.40
Q2 2021	15,138	$413	$28.17	$23.77 - $36.45
Q1 2021	169,487	$4,903	$31.23	$24.25 - $38.49
Q4 2020	78,973	$2,222	$24.49	$17.51 - $32.21